Sales rise 41.29% to Rs 15.33 crore
Net Loss of Parabolic Drugs reported to Rs 12.60 crore in the quarter ended June 2017 as against net loss of Rs 77.31 crore during the previous quarter ended June 2016. Sales rose 41.29% to Rs 15.33 crore in the quarter ended June 2017 as against Rs 10.85 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales15.3310.85 41 OPM %-35.42-298.06 -PBDT-3.51-63.93 95 PBT-12.16-77.31 84 NP-12.60-77.31 84Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
